Skip to content
OpenCapital
Get started

Corbus Pharmaceuticals CRBP Q4 2025 Annual earnings

Reported March 9, 2026 · Before market open

EPS-$1.25Beat by $0.53
Revenue estimate$1.7M
EPS estimate-$1.78

Next report

Aug 11, 2026 (In 1 week)
EPS estimate-$1.30

Versus estimates

Diluted EPS

Q1 2026-$1.23Beat by $0.03
Q4 2025-$1.25Beat by $0.53
Q3 2025-$1.90Miss by $0.10Q2 2025-$1.44Beat by $0.11Q1 2025-$1.39Miss by $0.13Q4 2024-$0.78Beat by $0.24

Ask the moment Corbus Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Corbus Pharmaceuticals report Q4 2025 earnings?
Corbus Pharmaceuticals (CRBP) reported Q4 2025 earnings on March 9, 2026 before market open.
What were Corbus Pharmaceuticals's Q4 2025 revenue and EPS?
Corbus Pharmaceuticals reported eps of $-1.25 for Q4 2025.
Did Corbus Pharmaceuticals beat estimates in Q4 2025?
EPS beat the consensus estimate of $-1.78 by $0.53.
How did Corbus Pharmaceuticals's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 60.3% from $-0.78.
Where can I find Corbus Pharmaceuticals's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-097582) and the 10-K periodic report (0001193125-26-098530) directly on SEC EDGAR. The filing index links above go to sec.gov.